Stay updated on Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.3%
- Check19 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check34 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.4%
- Check41 days agoChange DetectedThe page has been updated to reflect a new version (v2.16.0) and has removed an erratum related to a previous study on creatine kinase levels in ulcerative colitis patients.SummaryDifference1%
- Check55 days agoChange DetectedThe page has removed a citation regarding the efficacy and safety of tofacitinib, including an erratum reference.SummaryDifference0.1%
Stay in the know with updates to Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial page.